Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers

INTRODUCTION: This study aimed to determine the efficacy of combining plasma phosphorylated tau (p‐tau)181, amyloid beta (Aβ)42/Aβ40, neurofilament light (NfL), and apolipoprotein E (APOE) genotypes for detecting positive amyloid positron emission tomography (PET), which is little known in the Asian...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Hyuk Sung, Lee, Eun‐Hye, Kim, Hyung‐Ji, Park, So‐Hee, Park, Hyun‐Hee, Jeong, Jee Hyang, Koh, Seong‐Ho, Choi, Seong Hye, Lee, Jae‐Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654468/
https://www.ncbi.nlm.nih.gov/pubmed/38026758
http://dx.doi.org/10.1002/dad2.12502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654468/
https://www.ncbi.nlm.nih.gov/pubmed/38026758
http://dx.doi.org/10.1002/dad2.12502

Ejemplares similares